| Literature DB >> 30192816 |
Caryl Feldacker1,2, Aaron F Bochner1,3, Vernon Murenje4, Batsirai Makunike-Chikwinya4, Marrianne Holec1, Sinokuthemba Xaba5, Shirish Balachandra6, John Mandisarisa6, Vuyelwa Sidile-Chitimbire7, Scott Barnhart1,2,8, Mufuta Tshimanga9.
Abstract
BACKGROUND: Timing of routine follow-up visits after adult male circumcision (MC) differs by country and method. Most men do not attend all routine follow-up visits. This cross-sectional study aimed to further understanding of AE timing within a large-scale, routine, MC program to improve patient safety.Entities:
Mesh:
Year: 2018 PMID: 30192816 PMCID: PMC6128519 DOI: 10.1371/journal.pone.0203292
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1ZAZIC Organizational Model.
ZiCHIRe: Zimbabwe Community Health Intervention Project; ZACH: Zimbabwe Association of Church-related Hospitals; UZCHS-CTC: University of Zimbabwe College of Health Sciences—Clinical Trials Center.
Characteristics of clients with AEs by MC type: Surgical and PrePex.
| Surgical (n = 290) | PrePex (n = 131) | Total (n = 421) | |
|---|---|---|---|
| Age | |||
| Mean | 15.0 | 25.3 | 18.2 |
| Median (IQR) | 13 (11; 16). | 23 (19; 30) | 16 (12;21) |
| Client age group | |||
| 10–14 | 179 (61.7) | - | 179 (42.5) |
| 15–19 | 77 (26.6) | 45 (34.4) | 122 (29.0) |
| 20+ | 34 (11.7) | 86 (65.6) | 120 (28.5) |
| AE severity | |||
| Moderate | 227 (78.3) | 30 (22.9) | 257 (61.1) |
| Severe | 63 (21.7) | 101 (77.1) | 164 (38.9) |
| Facility site type | |||
| Static | 100 (34.4) | 60 (45.8) | 160 (38.0) |
| Outreach | 179 (61.7) | 65 (49.6) | 244 (58.0) |
| Unknown | 11 (3.8) | 6 (4.6) | 17 (4.0) |
| MC type | |||
| Dorsal slit | 169 (58.3) | - | 169 (40.1) |
| Forceps guided | 94 (32.4) | - | 94 (22.3) |
| Unspecified surgical | 26 (8.9) | - | 26 (6.2) |
| PrePex | - | 131 | 131 (31.1) |
| Unknown | 1 (0.03) | - | 1 (0.2) |
| Days to AE | |||
| Mean | 7.45 | 5.55 | 6.8 |
| Median (IQR) | 7 (4; 7) | 3 (2; 7) | 7 (3; 7) |
| AE timing | |||
| ≤ Day 2 | 55 (19.0) | 46 (35.1) | 101 (24.0) |
| Days 3–7 | 169 (58.3) | 59 (45.0) | 228 (54.2) |
| Days 8–14 | 47 (16.2) | 16 (12.2) | 63 (15.0) |
| Day 15+ | 19 (6.6) | 10 (7.6) | 29 (6.9) |
| PEPFAR AE type | |||
| Infection | 209 (72.1) | 23 (17.6) | 232 (55.1) |
| Device displacement | - | 94 (71.8) | 94 (22.3) |
| Bleeding | 59 (20.3) | 5 (3.8) | 64 (15.2) |
| Other (swelling, etc.) | 10 (3.5) | 3 (2.3) | 13 (3.1) |
| Scarring/disfigurement | 9 (3.1) | 1 (0.8) | 10 (2.4) |
| Pain | 2 (0.7) | 5 (3.8) | 7 (1.7) |
| Anesthesia-related | 1 (0.3) | - | 1 (0.24) |
IQR: Inter-quartile range (Q1; Q3).
Fig 2PrePex AEs by age group and AE timing.
PA: pain; OA: other AE (e.g., swelling); IN: infection; DD: device displacement; AN: anesthesia-related; BL: bleeding; SD scarring/disfigurement.
Fig 3Surgical AEs by age group and AE timing.
PA: pain; OA: other AE (e.g., swelling); IN: infection; DD: device displacement; AN: anesthesia-related; BL: bleeding; SD scarring/disfigurement.
Results of associations* between age, severity, and AE type and timing of AEs, by MC method.
| Row percentages | Surgical | PrePex | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ≤ Day 2 | Days 3–7 | Days 8–14 | Days 15+ | p-value | ≤ Day 2 | Days 3–7 | Days 8–14 | Days 15+ | p-value | |
| Client age group | <0.001 | 0.060 | ||||||||
| 10–14 | 21 | 115 | 28 | 15 | - | - | - | - | ||
| 15–19 | 17 | 40 | 17 | 3 | 13 | 18 | 7 | 7 | ||
| 20+ | 17 | 14 | 2 | 1 | 33 | 41 | 9 | 3 | ||
| AE severity | 0.004 | <0.001 | ||||||||
| Moderate | 35 | 143 | 37 | 12 | 2 | 10 | 13 | 5 | ||
| Severe | 20 | 26 | 10 | 7 | 44 | 49 | 3 | 5 | ||
| PEPFAR AE type | <0.001 | <0.001 | ||||||||
| Other | 54 | 21 | 4 | 2 | 0 | 9 | 4 | 1 | ||
| Infection | 1 | 148 | 43 | 17 | 1 | 4 | 9 | 9 | ||
| Device displacement | - | - | - | - | 45 | 46 | 3 | 0 | ||
*Results from chi-square tests.
**% are for within-category row proportions.